TRPM7 and ovarian carcinoma: Given that TRPM7 silencing reduced the levels of [Ca2+]i and treatment with MK886 inhibited TRPM7 expression we tested the impact of treatment with BAPTA-AM on the migration, invasion and wound healing in the TRPM7 silenced ovarian cancer cells.